Saturday, November 28, 2015 11:34:14 AM
Amarantus estimates the target patient population in the U.S. that would qualify for the study (i.e. TBSA = 50%) is between 500 and 2000 individuals. However, management believes that approximately 100,000 patients have burns with TBSA = 30%, meaning that a large market opportunity exists to expand the ESS development path should the initial Phase 2a study prove successful. On a global basis, burns with TBSA = 30% affect over 1 million.
The cost to care for a severely burned patient can range from $200,000 to over $1 million in hospital and physician’s fees alone.
In US, total patients with TBSA >= 50% is 2000.
In US, total patients with TBSA >= 30% is 100,000.
Cost per patient 200,000 to 1 million. I will take 500K as Average Cost.
TBSA >= 50% -> 2000 X 500,000 = 1,000,000,000 (1 Billion)
TBSA >= 30% -> 100,000 X 500,000 = 50,000,000,000 (50 Billion)
This is only US Market. Global market is estimated to have 1 million patients.
So 1,000,000 X 500,000 = 500 Billion Dollars Global Maket opportunity.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM